• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有胆管炎的肝脏侵袭性系统性肥大细胞增多症。

Aggressive systemic mastocytosis of the liver with cholangitis.

作者信息

Waldburger Nina, Rupp Christian, Klinke Sabine, Wieczorek Kathrin, Gotthardt Daniel, Kirchner Thomas, Schirmacher Peter, Straub Beate Katharina

机构信息

Department of General Pathology, Institute of Pathology, Heidelberg University Hospital, Im Neuenheimer Feld 224, D-69120 Heidelberg, Germany.

Department of Internal Medicine IV, Heidelberg University Hospital, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany.

出版信息

Hepat Oncol. 2015 Oct;2(4):343-347. doi: 10.2217/hep.15.33. Epub 2015 Nov 6.

DOI:10.2217/hep.15.33
PMID:30191016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6095320/
Abstract

Mastocytosis is a clonal, neoplastic mast cell proliferation, which is in most cases restricted to the skin (cutaneous mastocytosis), but may infiltrate other organs as well (systemic mastocytosis). Involvement of the liver by a systemic mastocytosis with impairment of liver function has been recognized as sign of an aggressive course of disease (C-finding). This article presents a case of aggressive systemic mastocytosis in a 26-year-old male patient with involvement of the liver mimicking primary sclerosing cholangitis. By histology we could demonstrate multifocal clusters of atypical mast cells infiltrating portal tracts in intimate contact with bile ducts as the cause of cholangitis and liver fibrosis.

摘要

肥大细胞增多症是一种克隆性肿瘤性肥大细胞增殖性疾病,大多数情况下局限于皮肤(皮肤肥大细胞增多症),但也可能浸润其他器官(系统性肥大细胞增多症)。系统性肥大细胞增多症累及肝脏并伴有肝功能损害已被认为是疾病侵袭性病程的标志(C级发现)。本文介绍了一例26岁男性侵袭性系统性肥大细胞增多症患者,其肝脏受累,酷似原发性硬化性胆管炎。通过组织学检查,我们发现多灶性非典型肥大细胞簇浸润门静脉区,与胆管紧密接触,这是胆管炎和肝纤维化的原因。

相似文献

1
Aggressive systemic mastocytosis of the liver with cholangitis.伴有胆管炎的肝脏侵袭性系统性肥大细胞增多症。
Hepat Oncol. 2015 Oct;2(4):343-347. doi: 10.2217/hep.15.33. Epub 2015 Nov 6.
2
Mast cell cholangiopathy: another cause of sclerosing cholangitis.肥大细胞胆管病:硬化性胆管炎的另一个病因。
Gastroenterology. 1995 Nov;109(5):1677-81. doi: 10.1016/0016-5085(95)90658-4.
3
Diagnostic criteria and classification of mastocytosis: a consensus proposal.肥大细胞增多症的诊断标准与分类:一项共识提议。
Leuk Res. 2001 Jul;25(7):603-25. doi: 10.1016/s0145-2126(01)00038-8.
4
Systemic mastocytosis: A rare cause of non-cirrhotic portal hypertension.系统性肥大细胞增多症:非肝硬化门静脉高压的罕见病因。
World J Gastroenterol. 2016 Jul 28;22(28):6559-64. doi: 10.3748/wjg.v22.i28.6559.
5
Mastocytosis in the skin accompanied by pseudo-Kaposi's sarcoma.皮肤肥大细胞增多症伴假性卡波西肉瘤。
J Dermatol. 2021 May;48(5):657-660. doi: 10.1111/1346-8138.15734. Epub 2021 Mar 8.
6
Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.色素性荨麻疹演变为惰性系统性肥大细胞增多症:肥大细胞免疫表型异常,无c-kit突变ASP-816-VAL证据
Leuk Lymphoma. 2003 Feb;44(2):313-9. doi: 10.1080/1042819021000037967.
7
Systemic mastocytosis: a rare cause of noncirrhotic portal hypertension simulating autoimmune cholangitis--report of four cases.系统性肥大细胞增多症:一种模拟自身免疫性胆管炎的非肝硬化门静脉高压的罕见病因——4例报告
Am J Gastroenterol. 1998 Jan;93(1):106-8. doi: 10.1111/j.1572-0241.1998.106_c.x.
8
The international consensus classification of mastocytosis and related entities.肥大细胞增多症及相关疾病的国际共识分类
Virchows Arch. 2023 Jan;482(1):99-112. doi: 10.1007/s00428-022-03423-3. Epub 2022 Oct 10.
9
Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.肥大细胞增多症最新进展(第二部分):分类、预后及治疗
Actas Dermosifiliogr. 2016 Jan-Feb;107(1):15-22. doi: 10.1016/j.ad.2015.09.009. Epub 2015 Oct 30.
10
Mastocytosis: state of the art.肥大细胞增多症:最新进展
Pathobiology. 2007;74(2):121-32. doi: 10.1159/000101711.

本文引用的文献

1
Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications.系统性肥大细胞增多症外周血中KIT D816V突变的检测:诊断意义
Mod Pathol. 2015 Aug;28(8):1138-49. doi: 10.1038/modpathol.2015.72. Epub 2015 Jun 12.
2
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event.多突变晚期系统性肥大细胞增多症中髓系前体细胞的分子谱分析确定 KIT D816V 为一个独特的晚期事件。
Leukemia. 2015 May;29(5):1115-22. doi: 10.1038/leu.2015.4. Epub 2015 Jan 8.
3
Education and Imaging. Hepatobiliary and pancreatic: systemic mastocytosis with portal hypertension.教育与影像。肝胆胰:系统性肥大细胞增多症伴门静脉高压。
J Gastroenterol Hepatol. 2014 Aug;29(8):1572. doi: 10.1111/jgh.12631.
4
An unusual case of aggressive systemic mastocytosis mimicking hepatic cirrhosis.一例表现为肝硬变样的侵袭性系统性肥大细胞增生症罕见病例。
Cancer Biol Med. 2014 Jun;11(2):134-8. doi: 10.7497/j.issn.2095-3941.2014.02.009.
5
A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.24 例累及胃肠道的系统性肥大细胞增多症的临床病理研究及肠易激综合征和无症状患者的黏膜肥大细胞密度评估。
Am J Surg Pathol. 2014 Jun;38(6):832-43. doi: 10.1097/PAS.0000000000000190.
6
Tyrosine kinase inhibitors in the treatment of systemic mastocytosis.酪氨酸激酶抑制剂治疗系统性肥大细胞增生症。
Leuk Res. 2011 Sep;35(9):1143-52. doi: 10.1016/j.leukres.2011.05.006. Epub 2011 Jun 8.
7
Unexplained and prolonged perioperative hypotension after orthotopic liver transplantation: undiagnosed systemic mastocytosis.
Liver Transpl. 2009 Jul;15(7):701-8. doi: 10.1002/lt.21762.
8
New aspects of liver abnormalities as part of the systemic mast cell activation syndrome.作为系统性肥大细胞活化综合征一部分的肝脏异常的新方面。
Liver Int. 2009 Feb;29(2):181-6. doi: 10.1111/j.1478-3231.2008.01839.x. Epub 2008 Jul 23.
9
Aggressive systemic mastocytosis presenting with hepatic cholestasis.以肝内胆汁淤积为表现的侵袭性系统性肥大细胞增多症。
Eur J Gastroenterol Hepatol. 2007 Oct;19(10):901-5. doi: 10.1097/MEG.0b013e3281ac20ba.
10
Cholestatic jaundice and bone lesions in an elderly woman.一位老年女性的胆汁淤积性黄疸和骨病变
Nat Clin Pract Gastroenterol Hepatol. 2004 Nov;1(1):53-7; quiz 1 p following 57. doi: 10.1038/ncpgasthep0026.